Trifluoroacetic acid → HCID 178511645, compound

HRID 2271719Notes

Reaction equation

[CH:1]1([C:4]([C:6]2[CH:7]=[N:8][C:9]3[C:14]([C:15]=2[NH:16][C@H:17]2[CH2:22][CH2:21][C@H:20]([NH:23]C(=O)OC(C)(C)C)[CH2:19][CH2:18]2)=[CH:13][C:12]([C:31]2[CH:36]=[C:35]([Cl:37])[C:34]([OH:38])=[CH:33][C:32]=2[Cl:39])=[CH:11][CH:10]=3)=[O:5])[CH2:3][CH2:2]1.C(O)(C(F)(F)F)=O>>[NH2:23][C@H:20]1[CH2:21][CH2:22][C@H:17]([NH:16][C:15]2[C:14]3[C:9](=[CH:10][CH:11]=[C:12]([C:31]4[CH:36]=[C:35]([Cl:37])[C:34]([OH:38])=[CH:33][C:32]=4[Cl:39])[CH:13]=3)[N:8]=[CH:7][C:6]=2[C:4]([CH:1]2[CH2:2][CH2:3]2)=[O:5])[CH2:18][CH2:19]1

Participants

Reactant 2

HCID 6422Trifluoroacetic acid

HCID 178454012HCID 178454012, compound

Product 1

HCID 178511645HCID 178511645, compoundYield 23%

Procedure

Following general procedure A-2, tert-butyl trans-4-[3-(cyclopropanecarbonyl)-6-(2,5-dichloro-4-hydroxyphenyl)quinolin-4-ylamino]cyclohexylcarbamate (57 mg, 0.100 mmol) was reacted with TFA (2 mL) to afford the desired product (10.8 mg, 23%) as an off-white solid: 1H NMR (500 MHz, CD3OD) δ 9.23 (s, 1H), 8.27 (d, J=1.6 Hz, 1H), 7.94 (d, J=8.6 Hz, 1H), 7.87 (dd, J=8.7, 1.7 Hz, 1H), 7.48 (s, 1H), 7.12 (s, 1H), 4.27-4.14 (m, 1H), 3.27-3.18 (m, 1H), 2.95-2.82 (m, 1H), 2.34 (d, J=11.5 Hz, 2H), 2.14 (d, J=10.7 Hz, 2H), 1.72-1.59 (m, 2H), 1.59-1.48 (m, 2H), 1.26-1.16 (m, 2H), 1.16-1.07 (m, 2H); ESI MS m/z 470 [C25H25Cl2N3O2+H]+; HPLC 96.4% (AUC), tR=10.67 min.

Sources & evidence

ORD record: ord-c0585bf5fd55495e8b535298cd569be9
Source dataset: uspto-grants-2015_09
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US09120749B2

Reaction notes

Loading…